Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/15/1995 | WO1995003426A3 Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor |
06/15/1995 | CA2178729A1 Compounds and methods for site-directed mutations in eukaryotic cells |
06/15/1995 | CA2178622A1 Humanized antibodies and uses thereof |
06/15/1995 | CA2178618A1 Nucleic acid mediated electron transfer |
06/15/1995 | CA2178598A1 Solution phase nucleic acid sandwich assays having reduced background noise |
06/15/1995 | CA2178590A1 Reagents and methods for the detection of methotrexate |
06/15/1995 | CA2178476A1 Pretargeting methods and compounds |
06/15/1995 | CA2178205A1 Method of selecting specific bacteriophages |
06/15/1995 | CA2177835A1 Methods and compositions for the suppression of neu mediated transformation |
06/15/1995 | CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof |
06/15/1995 | CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
06/15/1995 | CA2176949A1 Cytochrome p-450 monooxygenases |
06/15/1995 | CA2176825A1 C5a receptor antagonists having substantially no agonist activity |
06/15/1995 | CA2175482A1 Process for generating specific antibodies |
06/15/1995 | CA2155634A1 Method for the immobilization of nucleic acid molecules |
06/14/1995 | EP0657548A1 Amplification of nucleic acids in cells |
06/14/1995 | EP0657547A1 Method of assaying antithrombin iii activity and reagent kit therefor |
06/14/1995 | EP0657541A1 Novel entities for cancer therapy |
06/14/1995 | EP0657540A1 Novel entities for cancer therapy |
06/14/1995 | EP0657539A1 Novel entities for cancer therapy |
06/14/1995 | EP0657538A2 Process to produce engineered antibodies in plants, engineered antibodies and use thereof in diagnostics and therapeutics |
06/14/1995 | EP0657537A1 Secretory aspartic proteinase gene from Candida |
06/14/1995 | EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding |
06/14/1995 | EP0657535A2 A lipase gene originated from pseudomonas bacteria |
06/14/1995 | EP0657534A1 Antiallergic agent |
06/14/1995 | EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody |
06/14/1995 | EP0657532A1 HIV-3 retrovirus strains and their use |
06/14/1995 | EP0657530A2 Method for extracting nucleic acids from a wide range of organisms |
06/14/1995 | EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours |
06/14/1995 | EP0657470A2 Monoclonal antibodies against in vivo glycated albumin |
06/14/1995 | EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof |
06/14/1995 | EP0657468A1 Human stromae derived factor |
06/14/1995 | EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof |
06/14/1995 | EP0657029A1 Calcium receptor active molecules |
06/14/1995 | EP0656955A1 Elimination of false negatives in nucleic acid detection |
06/14/1995 | EP0656954A1 Method for producing tagged genes, transcripts, and proteins |
06/14/1995 | EP0656952A1 Cationic peptides and method for production |
06/14/1995 | EP0656951A1 Genetic sequences encoding flavonol synthase enzymes and uses therefor |
06/14/1995 | EP0656950A1 Tat-derived transport polypeptides |
06/14/1995 | EP0656949A1 Vaccinia virus b15r used in interleukin b1-involving condition |
06/14/1995 | EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE |
06/14/1995 | EP0656947A1 Human interleukin-13 |
06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
06/14/1995 | EP0656945A1 Stress protein epitopes |
06/14/1995 | EP0656944A1 Human melanocyte stimulating hormone receptor |
06/14/1995 | EP0656943A1 Fungal promoters active in the presence of glucose |
06/14/1995 | EP0656942A1 Compositions and methods for inhibiting growth or replication of viruses |
06/14/1995 | EP0656941A1 Methods for producing members of specific binding pairs |
06/14/1995 | EP0656940A1 Genetic sequences encoding glycosyltransferase enzymes and uses therefor |
06/14/1995 | EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
06/14/1995 | EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
06/14/1995 | EP0656790A1 Compositions and methods for modulating rna |
06/14/1995 | EP0656785A1 Method for inhibiting hiv replication using il-4 |
06/14/1995 | EP0656747A1 Composition and method for altering dna sequences by homologous recombination |
06/14/1995 | EP0521948B1 $g(g)-CGTase |
06/14/1995 | EP0494260B1 Granulocyte-colony stimulating factor receptors |
06/14/1995 | EP0465572B1 Genetic engineering of novel plant phenotypes |
06/13/1995 | US5424413 Branched nucleic acid probes |
06/13/1995 | US5424412 Construct comprising a promoter, a non-translated leader, and a 3'non-translated sequence that functions to cause addition of polyadenylated nucleotides to 3' end of RNA sequence |
06/13/1995 | US5424411 Genetic engineering |
06/13/1995 | US5424409 DNA constructs encoding Bacillus thuringiensis toxins from strain A20 |
06/13/1995 | US5424408 For detection, removal of Goodpasture antibodies in blood; autoimmune diseases |
06/13/1995 | US5424400 Senescent cell derived inhibitors of DNA synthesis |
06/13/1995 | US5424398 A polypeptide supporting with a solid as antibody inhibitor |
06/13/1995 | US5424395 Antimicrobial peptides active against plant pathogens |
06/13/1995 | US5424205 Complexing metalloprotease with an inhibitor, then exposure to an amyloid and monitoring to detect cleavage of methionine-aspartic acid bond |
06/13/1995 | US5424202 Ethanol production by recombinant hosts |
06/13/1995 | US5424200 Method for enhanced expression of a DNA sequence of interest |
06/13/1995 | US5424199 Human growth hormone |
06/13/1995 | US5424198 Human tPA production using vectors coding for DHFR protein |
06/13/1995 | US5424197 H. saimiri-HTLV-X region vector |
06/13/1995 | US5424196 Enzymatic process for preparing 7-aminocephalosporanic acid and derivatives |
06/13/1995 | US5424188 Amplified hybridization assay |
06/13/1995 | US5424185 Human high-affinity neurotransmitter uptake system |
06/13/1995 | US5424065 Comprising mutant Salmonella |
06/13/1995 | US5423778 System and method for transplantation of cells |
06/13/1995 | CA1335925C Process for recovering microbially produced interleukin-2 |
06/13/1995 | CA1335882C Process for preparing human factor viii:c employing expression vector containing chick _ -actin promoter |
06/11/1995 | CA2137760A1 Detection of nucleic acids in cells by strand displacement amplification |
06/09/1995 | EP0724646A4 Dna sequences related to isolated fragile x syndrome |
06/09/1995 | CA2136590A1 Recombinant genes expressing pp14 |
06/08/1995 | WO1995015401A1 Agarose plug mold and processing chamber |
06/08/1995 | WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
06/08/1995 | WO1995015395A2 Nucleoside analogue method |
06/08/1995 | WO1995015394A1 Targeted rna degradation using nuclear antisense rna |
06/08/1995 | WO1995015393A1 Novel expression screening vector |
06/08/1995 | WO1995015392A1 Chimeric geens and methods for increasing the lysine content of the seeds of corn, soybean and rapeseed plants |
06/08/1995 | WO1995015391A2 Aspergillus expression system |
06/08/1995 | WO1995015390A1 Aspergillus foetidus expression system |
06/08/1995 | WO1995015389A2 Promoter |
06/08/1995 | WO1995015388A1 Recombinant binding proteins and peptides |
06/08/1995 | WO1995015387A2 Nucleic acid sequences encoding a plant cytoplasmic protein involved in fatty acyl-coa metabolism |
06/08/1995 | WO1995015386A1 Novel receptor tyrosine kinase |
06/08/1995 | WO1995015385A1 Polypeptide having cold-resistant pyruvate phosphate dikinase activity, dna coding for the same, and recombinant vector and transformed plant both containing said dna |
06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
06/08/1995 | WO1995015383A2 Biological control agents |
06/08/1995 | WO1995015382A1 Binding structures directed against the ca55.1 antigen |
06/08/1995 | WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
06/08/1995 | WO1995015380A1 Rna polymerase transcription factor |
06/08/1995 | WO1995015379A1 Chicken oocyte receptor p95 (vldl/vtg receptor) |